PharmGen Science Statistics

Total Valuation

KRX:004720 has a market cap or net worth of KRW 78.20 billion. The enterprise value is 83.55 billion.

Market Cap	78.20B
Enterprise Value	83.55B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:004720 has 18.78 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	18.78M
Shares Outstanding	18.78M
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	-43.72%
Owned by Insiders (%)	11.55%
Owned by Institutions (%)	0.85%
Float	15.74M

Valuation Ratios

The trailing PE ratio is 664.15.

PE Ratio	664.15
Forward PE	n/a
PS Ratio	0.46
PB Ratio	0.31
P/TBV Ratio	0.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.05, with an EV/FCF ratio of -43.07.

EV / Earnings	709.55
EV / Sales	0.49
EV / EBITDA	12.05
EV / EBIT	36.27
EV / FCF	-43.07

Financial Position

The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.08.

Current Ratio	2.08
Quick Ratio	1.26
Debt / Equity	0.08
Debt / EBITDA	1.36
Debt / FCF	-10.01
Interest Coverage	2.32

Financial Efficiency

Return on equity (ROE) is 0.05% and return on invested capital (ROIC) is 2.23%.

Return on Equity (ROE)	0.05%
Return on Assets (ROA)	1.76%
Return on Invested Capital (ROIC)	2.23%
Return on Capital Employed (ROCE)	3.25%
Revenue Per Employee	759.55M
Profits Per Employee	521,017
Employee Count	226
Asset Turnover	0.50
Inventory Turnover	2.28

Taxes

Income Tax	-2.37B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.95% in the last 52 weeks. The beta is 0.22, so KRX:004720's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	-8.95%
50-Day Moving Average	4,112.90
200-Day Moving Average	4,241.83
Relative Strength Index (RSI)	57.86
Average Volume (20 Days)	58,024

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:004720 had revenue of KRW 171.66 billion and earned 117.75 million in profits. Earnings per share was 6.50.

Revenue	171.66B
Gross Profit	108.36B
Operating Income	9.66B
Pretax Income	-2.24B
Net Income	117.75M
EBITDA	14.29B
EBIT	9.66B
Earnings Per Share (EPS)	6.50

Full Income Statement

Balance Sheet

The company has 14.08 billion in cash and 19.42 billion in debt, giving a net cash position of -5.34 billion or -284.54 per share.

Cash & Cash Equivalents	14.08B
Total Debt	19.42B
Net Cash	-5.34B
Net Cash Per Share	-284.54
Equity (Book Value)	248.65B
Book Value Per Share	13,692.44
Working Capital	46.78B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.29 billion and capital expenditures -652.90 million, giving a free cash flow of -1.94 billion.

Operating Cash Flow	-1.29B
Capital Expenditures	-652.90M
Free Cash Flow	-1.94B
FCF Per Share	-103.31

Full Cash Flow Statement

Margins

Gross margin is 63.12%, with operating and profit margins of 5.63% and 0.07%.

Gross Margin	63.12%
Operating Margin	5.63%
Pretax Margin	-1.30%
Profit Margin	0.07%
EBITDA Margin	8.32%
EBIT Margin	5.63%
FCF Margin	n/a

Dividends & Yields

KRX:004720 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	-0.11%
Earnings Yield	0.15%
FCF Yield	-2.48%

Stock Splits

The last stock split was on November 17, 2014. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 17, 2014
Split Type	Reverse
Split Ratio	0.1

Scores

KRX:004720 has an Altman Z-Score of 1.9 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.9
Piotroski F-Score	4